id,PMID,title,journal,abstract,abstract_type,plain_language_summary,benefit_raw_answer,benefit_answer,benefit_log_probabilities,rigor_raw_answer,rigor_answer,rigor_log_probabilities,importance_raw_answer,importance_answer,importance_log_probabilities,full_text_raw_answer,full_text_answer,full_text_log_probabilities,another_trial_raw_answer,another_trial_answer,another_trial_log_probabilities
51,16314619,Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases,J Clin Oncol,"Purpose:
To determine whether treatment A, improves survival in patients with brain metastases when used as an adjunct to whole‐brain radiation therapy (WBRT).
Patients and methods:
Patients with brain metastases from solid tumors and a Karnofsky performance score of > or = 70 were randomly assigned to receive WBRT with supplemental oxygen and either treatment A (treatment A arm) or no treatment (control arm). The primary end point was survival.
Results:
The study consisted of 515 eligible patients (treatment A arm, n = 265; control arm, n = 250). The median survival time (MST) was 5.4 months for the treatment A arm versus 4.4 months for the control arm (hazard ratio [HR] = 0.87; P = .16). For the subgroup of patients with non‐small‐cell lung cancer (NSCLC) or breast cancer, the MST was 6.0 and 4.4 months, respectively (HR = 0.82; P = .07). Cox multiple regression analysis demonstrated a significant reduction in the risk of death for the treatment A arm in both primary populations. Further analysis indicated that the benefit may be restricted to the subgroup of patients with breast cancer. Response rates (radiographic complete response plus partial response) improved by 7% (P = .10) and 13% (P = .01) for all patients and for NSCLC and breast cancer patients in the treatment A arm, respectively. The most common severe adverse event in patients treated with treatment A was hypoxemia, which was reversible and effectively managed with supplemental oxygen in most patients.
Conclusion:
The addition of treatment A to WBRT may improve response rates and survival in patients with brain metastases, particularly metastases from breast cancer. A confirmatory trial for breast cancer patients has been initiated.",spin,"This passage is about a study that looked at whether a treatment called treatment A can help people with brain tumors live longer when used with radiation therapy. They studied 515 patients with brain tumors from different types of cancer. They found that adding treatment A to the radiation therapy may help patients with breast cancer live longer. The study also showed that treatment A improved how well the tumors responded to treatment. The most common side effect of treatment A was low oxygen levels, but it was manageable. They are now doing more research to confirm these findings for patients with breast cancer.",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.22481975}, {'token': '7', 'bytes': [55], 'logprob': -1.6573797}, {'token': '9', 'bytes': [57], 'logprob': -4.74112}, {'token': '6', 'bytes': [54], 'logprob': -6.313641}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -9.127391}, {'token': '5', 'bytes': [53], 'logprob': -10.135064}, {'token': 'I', 'bytes': [73], 'logprob': -11.543302}, {'token': '4', 'bytes': [52], 'logprob': -13.704793}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -13.801312}, {'token': '\n', 'bytes': [10], 'logprob': -14.112231}, {'token': ' ', 'bytes': [32], 'logprob': -15.404485}, {'token': '3', 'bytes': [51], 'logprob': -15.795901}, {'token': '10', 'bytes': [49, 48], 'logprob': -15.902249}, {'token': 'On', 'bytes': [79, 110], 'logprob': -16.979618}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.016161}, {'token': 'In', 'bytes': [73, 110], 'logprob': -17.406328}, {'token': 'Given', 'bytes': [71, 105, 118, 101, 110], 'logprob': -17.961823}, {'token': '2', 'bytes': [50], 'logprob': -18.08078}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -18.25041}, {'token': 'A', 'bytes': [65], 'logprob': -18.285097}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.03565828}, {'token': '9', 'bytes': [57], 'logprob': -3.8017564}, {'token': '7', 'bytes': [55], 'logprob': -4.372847}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -9.974394}, {'token': '6', 'bytes': [54], 'logprob': -10.374002}, {'token': 'I', 'bytes': [73], 'logprob': -12.490274}, {'token': '\n', 'bytes': [10], 'logprob': -14.576105}, {'token': '5', 'bytes': [53], 'logprob': -14.5874195}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -16.064785}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.071634}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -16.327402}, {'token': '10', 'bytes': [49, 48], 'logprob': -16.466667}, {'token': ' ', 'bytes': [32], 'logprob': -17.12274}, {'token': 'Overall', 'bytes': [79, 118, 101, 114, 97, 108, 108], 'logprob': -17.493256}, {'token': '4', 'bytes': [52], 'logprob': -18.369026}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.542274}, {'token': 'R', 'bytes': [82], 'logprob': -18.701952}, {'token': 'Rate', 'bytes': [82, 97, 116, 101], 'logprob': -19.037184}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -19.244267}, {'token': 'On', 'bytes': [79, 110], 'logprob': -19.472343}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.054439045}, {'token': '7', 'bytes': [55], 'logprob': -3.4353518}, {'token': '9', 'bytes': [57], 'logprob': -3.8780894}, {'token': '6', 'bytes': [54], 'logprob': -9.497718}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.992745}, {'token': '5', 'bytes': [53], 'logprob': -13.581637}, {'token': '\n', 'bytes': [10], 'logprob': -14.986585}, {'token': 'I', 'bytes': [73], 'logprob': -15.676438}, {'token': ' ', 'bytes': [32], 'logprob': -15.881873}, {'token': '10', 'bytes': [49, 48], 'logprob': -16.801575}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.2002}, {'token': '4', 'bytes': [52], 'logprob': -17.490034}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -18.15946}, {'token': 'Rate', 'bytes': [82, 97, 116, 101], 'logprob': -18.73746}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -18.953274}, {'token': 'In', 'bytes': [73, 110], 'logprob': -19.175024}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -19.317726}, {'token': '3', 'bytes': [51], 'logprob': -19.579012}, {'token': 'It', 'bytes': [73, 116], 'logprob': -19.644382}, {'token': 'A', 'bytes': [65], 'logprob': -19.713165}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.24752367}, {'token': '9', 'bytes': [57], 'logprob': -1.608909}, {'token': '7', 'bytes': [55], 'logprob': -3.9704661}, {'token': '6', 'bytes': [54], 'logprob': -8.853578}, {'token': '10', 'bytes': [49, 48], 'logprob': -9.085858}, {'token': '5', 'bytes': [53], 'logprob': -10.428193}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -11.608867}, {'token': 'I', 'bytes': [73], 'logprob': -13.763196}, {'token': '4', 'bytes': [52], 'logprob': -13.999621}, {'token': '\n', 'bytes': [10], 'logprob': -14.512963}, {'token': '3', 'bytes': [51], 'logprob': -15.313617}, {'token': ' ', 'bytes': [32], 'logprob': -15.444972}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -16.753565}, {'token': '1', 'bytes': [49], 'logprob': -17.284857}, {'token': '-', 'bytes': [45], 'logprob': -17.56336}, {'token': '2', 'bytes': [50], 'logprob': -17.648668}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.942732}, {'token': 'A', 'bytes': [65], 'logprob': -18.661839}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -18.697382}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.75828}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.63025916}, {'token': '9', 'bytes': [57], 'logprob': -0.76756155}, {'token': '7', 'bytes': [55], 'logprob': -5.777571}, {'token': '10', 'bytes': [49, 48], 'logprob': -8.142316}, {'token': '6', 'bytes': [54], 'logprob': -11.672442}, {'token': '\n', 'bytes': [10], 'logprob': -12.539811}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -13.622455}, {'token': '5', 'bytes': [53], 'logprob': -13.888076}, {'token': 'I', 'bytes': [73], 'logprob': -13.936435}, {'token': ' ', 'bytes': [32], 'logprob': -15.484487}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -15.997565}, {'token': 'It', 'bytes': [73, 116], 'logprob': -17.463963}, {'token': '4', 'bytes': [52], 'logprob': -17.724688}, {'token': '1', 'bytes': [49], 'logprob': -18.345259}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -18.391914}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -18.416096}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -18.54401}, {'token': '-', 'bytes': [45], 'logprob': -18.697895}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.943388}, {'token': '3', 'bytes': [51], 'logprob': -18.99596}]"
52,16314619,Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases,J Clin Oncol,"Purpose:
To determine whether treatment A, improves survival in patients with brain metastases when used as an adjunct to whole‐brain radiation therapy (WBRT).
Patients and methods:
Patients with brain metastases from solid tumors and a Karnofsky performance score of > or = 70 were randomly assigned to receive WBRT with supplemental oxygen and either treatment A (treatment A arm) or no treatment (control arm). The primary end point was survival.
Results:
The study consisted of 515 eligible patients (treatment A arm, n = 265; control arm, n = 250). The median survival time (MST) was 5.4 months for the treatment A arm versus 4.4 months for the control arm (hazard ratio [HR] = 0.87; P = .16). There was no statistically significant difference between the 2 groups for response rate (complete plus partial response) (46% for the treatment A arm and 38% for the control arm; P = .10). There was not a statistically significant difference in the cumulative incidence at 1 year after random assignment of radiographic (21% treatment A vs. 18% control; p=0.53) or clinical progression (49% treatment A vs. 51% control; p = 0.49) in the brain between the treatment groups. At 6 months, respectively 16% and 15% of the patients had a stable or improving quality of life in treatment A arm and control arm. The most common severe adverse event in patients treated with treatment A was hypoxemia.
Conclusion:
The addition of treatment A to WBRT was not more effective than WBRT alone in patients with brain metastases.",no_spin,"This passage is about a study that looked at whether adding treatment A to whole-brain radiation therapy helps people with brain tumors live longer. They studied 515 patients with brain tumors and found that adding treatment A did not make a big difference in how long they lived compared to just getting radiation therapy. The study also found that the side effect of treatment A was low oxygen levels in the blood. In conclusion, adding treatment A to radiation therapy did not improve survival for patients with brain tumors.",2,2,"[{'token': '2', 'bytes': [50], 'logprob': -0.35218108}, {'token': '3', 'bytes': [51], 'logprob': -1.2781492}, {'token': '4', 'bytes': [52], 'logprob': -4.072476}, {'token': '1', 'bytes': [49], 'logprob': -6.7492414}, {'token': '5', 'bytes': [53], 'logprob': -9.700786}, {'token': '0', 'bytes': [48], 'logprob': -10.62276}, {'token': '6', 'bytes': [54], 'logprob': -13.707767}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -13.92842}, {'token': '\n', 'bytes': [10], 'logprob': -15.747138}, {'token': ' ', 'bytes': [32], 'logprob': -15.766437}, {'token': '7', 'bytes': [55], 'logprob': -16.536291}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -18.080324}, {'token': '-', 'bytes': [45], 'logprob': -18.26363}, {'token': 'I', 'bytes': [73], 'logprob': -18.96829}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -18.99721}, {'token': 'score', 'bytes': [115, 99, 111, 114, 101], 'logprob': -20.433102}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -20.584845}, {'token': '<|end|>', 'bytes': None, 'logprob': -20.768356}, {'token': '8', 'bytes': [56], 'logprob': -20.936968}, {'token': 'It', 'bytes': [73, 116], 'logprob': -20.981647}]",7,7,"[{'token': '7', 'bytes': [55], 'logprob': -0.84581023}, {'token': '6', 'bytes': [54], 'logprob': -0.89020187}, {'token': '5', 'bytes': [53], 'logprob': -2.0877688}, {'token': '8', 'bytes': [56], 'logprob': -3.854252}, {'token': '4', 'bytes': [52], 'logprob': -4.2351346}, {'token': '3', 'bytes': [51], 'logprob': -7.593308}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -10.081461}, {'token': '2', 'bytes': [50], 'logprob': -10.846689}, {'token': '9', 'bytes': [57], 'logprob': -10.870361}, {'token': '\n', 'bytes': [10], 'logprob': -13.2217045}, {'token': ' ', 'bytes': [32], 'logprob': -14.945259}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -15.755047}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -15.790165}, {'token': '1', 'bytes': [49], 'logprob': -15.883396}, {'token': 'I', 'bytes': [73], 'logprob': -16.483446}, {'token': 'Overall', 'bytes': [79, 118, 101, 114, 97, 108, 108], 'logprob': -17.312849}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.474623}, {'token': '-', 'bytes': [45], 'logprob': -17.845985}, {'token': 'S', 'bytes': [83], 'logprob': -18.033665}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -18.084866}]",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -0.8492639}, {'token': '6', 'bytes': [54], 'logprob': -1.5186975}, {'token': '7', 'bytes': [55], 'logprob': -1.7121446}, {'token': '4', 'bytes': [52], 'logprob': -1.9565828}, {'token': '3', 'bytes': [51], 'logprob': -3.7629678}, {'token': '8', 'bytes': [56], 'logprob': -4.9730396}, {'token': '2', 'bytes': [50], 'logprob': -6.659027}, {'token': '9', 'bytes': [57], 'logprob': -10.43713}, {'token': '1', 'bytes': [49], 'logprob': -12.995523}, {'token': ' ', 'bytes': [32], 'logprob': -13.170891}, {'token': '\n', 'bytes': [10], 'logprob': -13.695343}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -14.801361}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.17879}, {'token': '0', 'bytes': [48], 'logprob': -16.560043}, {'token': 'I', 'bytes': [73], 'logprob': -17.034508}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.316492}, {'token': '-', 'bytes': [45], 'logprob': -17.720104}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -18.503572}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.530054}, {'token': '<|end|>', 'bytes': None, 'logprob': -18.624138}]",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -1.0741876}, {'token': '3', 'bytes': [51], 'logprob': -1.3328279}, {'token': '4', 'bytes': [52], 'logprob': -1.533214}, {'token': '2', 'bytes': [50], 'logprob': -1.9716524}, {'token': '7', 'bytes': [55], 'logprob': -3.733192}, {'token': '6', 'bytes': [54], 'logprob': -4.4279475}, {'token': '8', 'bytes': [56], 'logprob': -5.6489863}, {'token': '1', 'bytes': [49], 'logprob': -8.465344}, {'token': '9', 'bytes': [57], 'logprob': -10.65854}, {'token': '0', 'bytes': [48], 'logprob': -11.152205}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -14.094623}, {'token': ' ', 'bytes': [32], 'logprob': -14.320613}, {'token': '\n', 'bytes': [10], 'logprob': -14.632991}, {'token': 'I', 'bytes': [73], 'logprob': -15.979379}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.023573}, {'token': '-', 'bytes': [45], 'logprob': -17.210535}, {'token': '10', 'bytes': [49, 48], 'logprob': -17.422474}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -18.757322}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -18.806175}, {'token': '<|end|>', 'bytes': None, 'logprob': -19.292786}]",3,3,"[{'token': '3', 'bytes': [51], 'logprob': -0.72754943}, {'token': '2', 'bytes': [50], 'logprob': -1.2743748}, {'token': '4', 'bytes': [52], 'logprob': -1.8123273}, {'token': '5', 'bytes': [53], 'logprob': -2.61732}, {'token': '6', 'bytes': [54], 'logprob': -7.588916}, {'token': '1', 'bytes': [49], 'logprob': -8.07532}, {'token': '7', 'bytes': [55], 'logprob': -8.597312}, {'token': '0', 'bytes': [48], 'logprob': -10.816007}, {'token': '8', 'bytes': [56], 'logprob': -11.673678}, {'token': ' ', 'bytes': [32], 'logprob': -15.22321}, {'token': '\n', 'bytes': [10], 'logprob': -15.636273}, {'token': '9', 'bytes': [57], 'logprob': -17.080427}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.540852}, {'token': 'I', 'bytes': [73], 'logprob': -18.404615}, {'token': '-', 'bytes': [45], 'logprob': -18.453302}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -18.830915}, {'token': '<|end|>', 'bytes': None, 'logprob': -19.458265}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -19.680645}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -19.9304}, {'token': 'It', 'bytes': [73, 116], 'logprob': -19.998281}]"
37,16504757,A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results,Int J Radiat Oncol Biol Phys,"Purpose:
To compare treatment A and comparator B in node‐positive, operable breast cancer patients.
Methods and materials:
This was a randomized, multicenter, phase III trial enrolling 638 eligible women with prior breast surgery and positive axillary dissection. Patients in Arm A received treatment A, with concomitant radiotherapy (50 Gy +/‐ 10‐20‐Gy boost). Patients in Arm B received comparator B, with subsequent radiotherapy.
Results:
Median treatment durations were 64 and 126 days (Arms A and B, respectively), with no significant difference in overall or disease‐free survival. Five‐year locoregional relapse‐free survival favored patients with conservative surgery (two thirds of the population), with less local and / or regional recurrence in Arm A than in Arm B (3% vs. 9%; p = 0.01). Multivariate analysis in this subgroup showed a 2.8‐fold increased risk of locoregional recurrence with comparator B, independent of other prognostic factors (p = 0.027). Febrile neutropenia and Grade 3‐4 leukopenia were significantly more frequent in Arm A. Subclinical left ventricular ejection fraction events at 1 year were more frequent with treatment A (p = 0.02).
Conclusion:
Treatment A has significantly better locoregional control in node‐positive breast cancer after conservative surgery and 50% shorter treatment, albeit with slightly more acute toxicity.",spin,"This passage is about a study that compared two different treatments for breast cancer. One treatment (A) had better control of the cancer spreading to nearby areas, but caused more side effects. The other treatment (B) took longer to complete and had a higher risk of the cancer coming back in the same area. Overall, treatment A was found to be more effective in controlling the cancer near the breast, even though it had more side effects.",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.20392045}, {'token': '7', 'bytes': [55], 'logprob': -2.0884266}, {'token': '9', 'bytes': [57], 'logprob': -2.8427143}, {'token': '6', 'bytes': [54], 'logprob': -6.1237125}, {'token': '5', 'bytes': [53], 'logprob': -9.090408}, {'token': '4', 'bytes': [52], 'logprob': -12.06274}, {'token': 'I', 'bytes': [73], 'logprob': -12.257572}, {'token': '10', 'bytes': [49, 48], 'logprob': -12.520721}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.7580185}, {'token': '\n', 'bytes': [10], 'logprob': -13.198954}, {'token': '3', 'bytes': [51], 'logprob': -13.854919}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -15.625294}, {'token': ' ', 'bytes': [32], 'logprob': -15.902567}, {'token': '2', 'bytes': [50], 'logprob': -15.978844}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -16.974619}, {'token': '1', 'bytes': [49], 'logprob': -17.040459}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.413393}, {'token': 'It', 'bytes': [73, 116], 'logprob': -17.624905}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.018173}, {'token': 'On', 'bytes': [79, 110], 'logprob': -18.935366}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.06939128}, {'token': '7', 'bytes': [55], 'logprob': -3.0663242}, {'token': '9', 'bytes': [57], 'logprob': -3.8991413}, {'token': '6', 'bytes': [54], 'logprob': -8.645475}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.10758}, {'token': '\n', 'bytes': [10], 'logprob': -12.874586}, {'token': '5', 'bytes': [53], 'logprob': -12.938749}, {'token': 'I', 'bytes': [73], 'logprob': -16.081606}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.194578}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -16.23199}, {'token': '4', 'bytes': [52], 'logprob': -16.609272}, {'token': '10', 'bytes': [49, 48], 'logprob': -16.713472}, {'token': 'Overall', 'bytes': [79, 118, 101, 114, 97, 108, 108], 'logprob': -17.23037}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -17.252337}, {'token': ' ', 'bytes': [32], 'logprob': -17.447395}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.628809}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.648273}, {'token': 'R', 'bytes': [82], 'logprob': -18.715546}, {'token': '3', 'bytes': [51], 'logprob': -18.741405}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -18.820978}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.12865773}, {'token': '7', 'bytes': [55], 'logprob': -2.3149524}, {'token': '9', 'bytes': [57], 'logprob': -3.8351512}, {'token': '6', 'bytes': [54], 'logprob': -7.9729075}, {'token': '5', 'bytes': [53], 'logprob': -11.8745985}, {'token': '\n', 'bytes': [10], 'logprob': -13.178935}, {'token': 'I', 'bytes': [73], 'logprob': -13.597699}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -13.909795}, {'token': '4', 'bytes': [52], 'logprob': -15.834796}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.073488}, {'token': ' ', 'bytes': [32], 'logprob': -16.32616}, {'token': '10', 'bytes': [49, 48], 'logprob': -16.594164}, {'token': 'In', 'bytes': [73, 110], 'logprob': -17.594704}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.63746}, {'token': '3', 'bytes': [51], 'logprob': -18.109148}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -18.18673}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -18.251509}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -18.798098}, {'token': 'It', 'bytes': [73, 116], 'logprob': -18.816572}, {'token': 'Rate', 'bytes': [82, 97, 116, 101], 'logprob': -18.826439}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.20343773}, {'token': '7', 'bytes': [55], 'logprob': -1.9271125}, {'token': '9', 'bytes': [57], 'logprob': -3.4368057}, {'token': '6', 'bytes': [54], 'logprob': -5.4002113}, {'token': '5', 'bytes': [53], 'logprob': -6.352768}, {'token': '4', 'bytes': [52], 'logprob': -9.656952}, {'token': '3', 'bytes': [51], 'logprob': -11.408173}, {'token': '\n', 'bytes': [10], 'logprob': -12.549223}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.582624}, {'token': '10', 'bytes': [49, 48], 'logprob': -13.402489}, {'token': '2', 'bytes': [50], 'logprob': -13.663521}, {'token': 'I', 'bytes': [73], 'logprob': -13.937059}, {'token': ' ', 'bytes': [32], 'logprob': -15.279173}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -15.929783}, {'token': '1', 'bytes': [49], 'logprob': -15.943441}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.336065}, {'token': '-', 'bytes': [45], 'logprob': -17.491978}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -17.774382}, {'token': '0', 'bytes': [48], 'logprob': -18.081472}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.49216}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.126066}, {'token': '9', 'bytes': [57], 'logprob': -2.7849252}, {'token': '7', 'bytes': [55], 'logprob': -2.8861368}, {'token': '6', 'bytes': [54], 'logprob': -7.1243725}, {'token': '5', 'bytes': [53], 'logprob': -9.156874}, {'token': '\n', 'bytes': [10], 'logprob': -12.661074}, {'token': '4', 'bytes': [52], 'logprob': -13.022953}, {'token': '10', 'bytes': [49, 48], 'logprob': -13.781282}, {'token': 'I', 'bytes': [73], 'logprob': -14.769693}, {'token': '3', 'bytes': [51], 'logprob': -14.930033}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -15.467871}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -16.14173}, {'token': ' ', 'bytes': [32], 'logprob': -16.66338}, {'token': '2', 'bytes': [50], 'logprob': -16.737946}, {'token': 'It', 'bytes': [73, 116], 'logprob': -17.804785}, {'token': '1', 'bytes': [49], 'logprob': -17.906082}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -18.08257}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -18.347343}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -18.97923}, {'token': 'In', 'bytes': [73, 110], 'logprob': -19.299759}]"
38,16504757,A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results,Int J Radiat Oncol Biol Phys,"Purpose:
To compare treatment A and comparator B in node‐positive, operable breast cancer patients.
Methods and materials:
This was a randomized, multicenter, phase III trial enrolling 638 eligible women with prior breast surgery and positive axillary dissection. Patients in Arm A received treatment A, with concomitant radiotherapy (50 Gy +/‐ 10‐20‐Gy boost). Patients in Arm B received comparator B, with subsequent radiotherapy. The primary outcome was disease free survival.
Results:
650 women were enrolled in this trial, and a total of 638 patients were treated. Median treatment durations were 64 and 126 days (Arms A and B, respectively). Five‐year DFS in Arm A was 83% and in Arm B 79%, p = 0.22. Disease‐specific survival at 5 years was not statistically significantly different between Arm A and Arm B. Sixty‐eight patients died 34 in each group. There was no statistically significant difference at 5 years for regional or metastatic relapses. Local recurrences at 5 years was 3% in Arm A and 7% in Arm B, p=0.047). Febrile neutropenia (n=10 in arm A vs. n=1 in arm B) and Grade 3‐4 leukopenia (n=43 vs n=4) were statistically significantly more frequent in Arm A. Subclinical left ventricular ejection fraction events at 1 year were more frequent with treatment A (p=0.02).
Conclusion:
Treatment A was not more effective than comparator B in node‐positive, operable breast cancer patients.",no_spin,"This passage is about a study that compared two different treatments for breast cancer. One group of patients received treatment A with radiation therapy, while the other group received treatment B with radiation therapy later on. The study found that there was no significant difference in survival rates between the two groups after five years. However, patients in group A had more side effects like febrile neutropenia and heart problems compared to those in group B. In conclusion, treatment A was not found to be more effective than treatment B for breast cancer patients with cancer in their lymph nodes.",2,2,"[{'token': '2', 'bytes': [50], 'logprob': -0.2636013}, {'token': '3', 'bytes': [51], 'logprob': -1.6795483}, {'token': '4', 'bytes': [52], 'logprob': -3.2310238}, {'token': '1', 'bytes': [49], 'logprob': -5.3418026}, {'token': '5', 'bytes': [53], 'logprob': -7.1292934}, {'token': '0', 'bytes': [48], 'logprob': -8.895323}, {'token': '6', 'bytes': [54], 'logprob': -11.154961}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.75419}, {'token': '7', 'bytes': [55], 'logprob': -13.608572}, {'token': '\n', 'bytes': [10], 'logprob': -14.308382}, {'token': ' ', 'bytes': [32], 'logprob': -15.12743}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -16.466265}, {'token': '8', 'bytes': [56], 'logprob': -17.67898}, {'token': '-', 'bytes': [45], 'logprob': -17.767939}, {'token': 'I', 'bytes': [73], 'logprob': -18.275194}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -18.292532}, {'token': '<|end|>', 'bytes': None, 'logprob': -19.197922}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -19.410114}, {'token': '9', 'bytes': [57], 'logprob': -19.55018}, {'token': 'score', 'bytes': [115, 99, 111, 114, 101], 'logprob': -19.616692}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.36414456}, {'token': '7', 'bytes': [55], 'logprob': -1.2377484}, {'token': '9', 'bytes': [57], 'logprob': -4.906251}, {'token': '6', 'bytes': [54], 'logprob': -4.9105005}, {'token': '5', 'bytes': [53], 'logprob': -7.8561144}, {'token': '4', 'bytes': [52], 'logprob': -11.528771}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.504365}, {'token': '\n', 'bytes': [10], 'logprob': -13.583079}, {'token': '3', 'bytes': [51], 'logprob': -14.084674}, {'token': 'I', 'bytes': [73], 'logprob': -15.456458}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -15.776076}, {'token': ' ', 'bytes': [32], 'logprob': -15.95044}, {'token': '10', 'bytes': [49, 48], 'logprob': -16.043745}, {'token': '2', 'bytes': [50], 'logprob': -16.272945}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -16.7126}, {'token': 'Overall', 'bytes': [79, 118, 101, 114, 97, 108, 108], 'logprob': -17.428865}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -17.745071}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.935986}, {'token': '-', 'bytes': [45], 'logprob': -18.221718}, {'token': '1', 'bytes': [49], 'logprob': -18.380604}]",7,7,"[{'token': '7', 'bytes': [55], 'logprob': -0.7877089}, {'token': '8', 'bytes': [56], 'logprob': -0.8140379}, {'token': '6', 'bytes': [54], 'logprob': -2.7686124}, {'token': '5', 'bytes': [53], 'logprob': -3.8288121}, {'token': '9', 'bytes': [57], 'logprob': -4.195851}, {'token': '4', 'bytes': [52], 'logprob': -6.0821233}, {'token': '3', 'bytes': [51], 'logprob': -8.577888}, {'token': '2', 'bytes': [50], 'logprob': -10.811318}, {'token': '\n', 'bytes': [10], 'logprob': -11.700597}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.873956}, {'token': ' ', 'bytes': [32], 'logprob': -13.005239}, {'token': '1', 'bytes': [49], 'logprob': -14.42475}, {'token': '10', 'bytes': [49, 48], 'logprob': -15.021913}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -15.414634}, {'token': 'I', 'bytes': [73], 'logprob': -16.188229}, {'token': '-', 'bytes': [45], 'logprob': -16.19346}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.329271}, {'token': '0', 'bytes': [48], 'logprob': -16.434744}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -17.355408}, {'token': 'In', 'bytes': [73, 110], 'logprob': -17.499016}]",8,8,"[{'token': '8', 'bytes': [56], 'logprob': -0.64542204}, {'token': '7', 'bytes': [55], 'logprob': -1.1351376}, {'token': '5', 'bytes': [53], 'logprob': -2.6703014}, {'token': '9', 'bytes': [57], 'logprob': -3.3177547}, {'token': '6', 'bytes': [54], 'logprob': -3.5529156}, {'token': '4', 'bytes': [52], 'logprob': -4.577242}, {'token': '3', 'bytes': [51], 'logprob': -4.786104}, {'token': '2', 'bytes': [50], 'logprob': -6.5733147}, {'token': '10', 'bytes': [49, 48], 'logprob': -10.780249}, {'token': '1', 'bytes': [49], 'logprob': -10.990595}, {'token': '0', 'bytes': [48], 'logprob': -12.343952}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.420174}, {'token': '\n', 'bytes': [10], 'logprob': -13.610788}, {'token': ' ', 'bytes': [32], 'logprob': -13.86372}, {'token': 'I', 'bytes': [73], 'logprob': -14.339556}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -15.906359}, {'token': '-', 'bytes': [45], 'logprob': -16.365578}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -17.24056}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.629217}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.220507}]",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -0.6896519}, {'token': '4', 'bytes': [52], 'logprob': -1.381329}, {'token': '3', 'bytes': [51], 'logprob': -2.1029286}, {'token': '2', 'bytes': [50], 'logprob': -3.1043706}, {'token': '7', 'bytes': [55], 'logprob': -3.2671018}, {'token': '6', 'bytes': [54], 'logprob': -3.3333364}, {'token': '8', 'bytes': [56], 'logprob': -5.106541}, {'token': '1', 'bytes': [49], 'logprob': -8.910124}, {'token': '9', 'bytes': [57], 'logprob': -9.750174}, {'token': '0', 'bytes': [48], 'logprob': -11.627436}, {'token': '\n', 'bytes': [10], 'logprob': -12.822268}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -14.163973}, {'token': ' ', 'bytes': [32], 'logprob': -15.256123}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -15.70846}, {'token': 'I', 'bytes': [73], 'logprob': -16.813272}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -17.796581}, {'token': '10', 'bytes': [49, 48], 'logprob': -17.99682}, {'token': '-', 'bytes': [45], 'logprob': -18.133932}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -18.217535}, {'token': 'It', 'bytes': [73, 116], 'logprob': -18.66475}]"
7,21399726,"The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)",J Support Oncol,"Sleep disorders are a substantial problem for cancer survivors, with prevalence estimates ranging from 23% to 61%. Although numerous prescription hypnotics are available, few are approved for long‐term use or have demonstrated benefit in this circumstance. Hypnotics may have unwanted side effects and are costly, and cancer survivors often wish to avoid prescription drugs. New options with limited side effects are needed. The purpose of this trial was to evaluate the efficacy of treatment A for sleep in people with cancer who were undergoing cancer treatment. Participants were randomized to receive treatment A or placebo orally 1 hour before bedtime for 8 weeks. The primary end point was area under the curve (AUC) of the overall Pittsburgh Sleep Quality Index (PSQI). Secondary outcomes included the Functional Outcomes of Sleep Questionnaire, the Brief Fatigue Inventory (BFI), and the Profile of Mood States (POMS). Toxicity was evaluated with both self‐reported numeric analogue scale questions and the Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. Questionnaires were completed at baseline and at 4 and 8 weeks. A total of 227 patients were randomized into this study between March 19, 2004, and March 9, 2007, with 119 being evaluable for the primary end point. The AUC over the 8 weeks for treatment A was 51.4 (SD = 16), while that for placebo was 49.7 (SD = 15), with a P value of 0.6957. A supplemental, exploratory analysis revealed that several fatigue end points, as measured by the BFI and POMS, were significantly better for those taking treatment A over placebo. Participants also reported less trouble with sleep and less drowsiness on treatment A than placebo. There were no significant differences in toxicities as measured by self‐report or the CTCAE except for mild alkaline phosphatase increases, which were slightly more common in the placebo group. This study failed to provide data to support the hypothesis that treatment A, at bedtime could improve sleep as measured by the PSQI. However, exploratory analyses revealed improvement in some secondary outcomes, such as fatigue. Further research with treatment A exploring physiologic effects in oncology symptom management may be warranted.",spin,"This passage is about how many cancer survivors have trouble sleeping, and how doctors are trying to find better ways to help them sleep. They did a study where some patients took a new treatment before bed, while others took a fake pill. The study found that the new treatment didn't make a big difference in overall sleep quality, but it did help with things like feeling tired and having trouble sleeping. More research is needed to see if this treatment can help with other symptoms of cancer.",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -0.7678529}, {'token': '6', 'bytes': [54], 'logprob': -1.1666795}, {'token': '4', 'bytes': [52], 'logprob': -1.8727723}, {'token': '7', 'bytes': [55], 'logprob': -2.8393326}, {'token': '3', 'bytes': [51], 'logprob': -4.4415207}, {'token': '8', 'bytes': [56], 'logprob': -7.743536}, {'token': '2', 'bytes': [50], 'logprob': -8.482868}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.001732}, {'token': '9', 'bytes': [57], 'logprob': -13.031979}, {'token': '1', 'bytes': [49], 'logprob': -13.204248}, {'token': ' ', 'bytes': [32], 'logprob': -14.228312}, {'token': '\n', 'bytes': [10], 'logprob': -14.539255}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -14.571175}, {'token': 'I', 'bytes': [73], 'logprob': -14.888634}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.666147}, {'token': '0', 'bytes': [48], 'logprob': -17.020014}, {'token': 'It', 'bytes': [73, 116], 'logprob': -17.167713}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.190897}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.176228}, {'token': '-', 'bytes': [45], 'logprob': -18.214497}]",7,7,"[{'token': '7', 'bytes': [55], 'logprob': -0.42470974}, {'token': '6', 'bytes': [54], 'logprob': -1.3807836}, {'token': '8', 'bytes': [56], 'logprob': -2.9195523}, {'token': '5', 'bytes': [53], 'logprob': -3.2873425}, {'token': '4', 'bytes': [52], 'logprob': -5.7435346}, {'token': '3', 'bytes': [51], 'logprob': -9.373022}, {'token': '9', 'bytes': [57], 'logprob': -9.934708}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -11.849815}, {'token': '2', 'bytes': [50], 'logprob': -12.93939}, {'token': 'I', 'bytes': [73], 'logprob': -14.275307}, {'token': '\n', 'bytes': [10], 'logprob': -14.76185}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -15.209963}, {'token': ' ', 'bytes': [32], 'logprob': -15.679914}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -16.34032}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -16.883293}, {'token': '1', 'bytes': [49], 'logprob': -16.96132}, {'token': 'Overall', 'bytes': [79, 118, 101, 114, 97, 108, 108], 'logprob': -17.080269}, {'token': '-', 'bytes': [45], 'logprob': -17.811262}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.029629}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -18.979671}]",7,7,"[{'token': '7', 'bytes': [55], 'logprob': -0.28670263}, {'token': '6', 'bytes': [54], 'logprob': -1.9607558}, {'token': '8', 'bytes': [56], 'logprob': -2.5691314}, {'token': '5', 'bytes': [53], 'logprob': -3.4960074}, {'token': '4', 'bytes': [52], 'logprob': -6.6596694}, {'token': '9', 'bytes': [57], 'logprob': -8.2735195}, {'token': '3', 'bytes': [51], 'logprob': -9.887705}, {'token': '2', 'bytes': [50], 'logprob': -13.311569}, {'token': '\n', 'bytes': [10], 'logprob': -13.325754}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -13.468246}, {'token': ' ', 'bytes': [32], 'logprob': -15.082026}, {'token': 'I', 'bytes': [73], 'logprob': -16.993773}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.00674}, {'token': '1', 'bytes': [49], 'logprob': -17.023846}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.885517}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -18.06393}, {'token': '10', 'bytes': [49, 48], 'logprob': -18.703686}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.80372}, {'token': '-', 'bytes': [45], 'logprob': -19.087734}, {'token': '0', 'bytes': [48], 'logprob': -19.664406}]",7,7,"[{'token': '7', 'bytes': [55], 'logprob': -0.6839444}, {'token': '8', 'bytes': [56], 'logprob': -1.0055845}, {'token': '5', 'bytes': [53], 'logprob': -2.8718565}, {'token': '6', 'bytes': [54], 'logprob': -2.8743742}, {'token': '4', 'bytes': [52], 'logprob': -4.8286242}, {'token': '9', 'bytes': [57], 'logprob': -5.188411}, {'token': '3', 'bytes': [51], 'logprob': -5.898763}, {'token': '2', 'bytes': [50], 'logprob': -8.687265}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -11.786535}, {'token': '1', 'bytes': [49], 'logprob': -13.621716}, {'token': ' ', 'bytes': [32], 'logprob': -14.058283}, {'token': 'I', 'bytes': [73], 'logprob': -14.062304}, {'token': '\n', 'bytes': [10], 'logprob': -14.801668}, {'token': '10', 'bytes': [49, 48], 'logprob': -14.834583}, {'token': '0', 'bytes': [48], 'logprob': -15.819658}, {'token': '-', 'bytes': [45], 'logprob': -16.325375}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.268198}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.347569}, {'token': 'In', 'bytes': [73, 110], 'logprob': -18.40835}, {'token': 'A', 'bytes': [65], 'logprob': -18.437408}]",7,7,"[{'token': '7', 'bytes': [55], 'logprob': -0.50348264}, {'token': '8', 'bytes': [56], 'logprob': -1.2196538}, {'token': '6', 'bytes': [54], 'logprob': -2.8424757}, {'token': '5', 'bytes': [53], 'logprob': -3.2930372}, {'token': '4', 'bytes': [52], 'logprob': -6.060707}, {'token': '9', 'bytes': [57], 'logprob': -6.1670227}, {'token': '3', 'bytes': [51], 'logprob': -7.9097023}, {'token': '2', 'bytes': [50], 'logprob': -10.744177}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -13.140005}, {'token': '\n', 'bytes': [10], 'logprob': -13.298464}, {'token': '1', 'bytes': [49], 'logprob': -14.906527}, {'token': ' ', 'bytes': [32], 'logprob': -15.47471}, {'token': 'I', 'bytes': [73], 'logprob': -15.665054}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -16.706997}, {'token': '0', 'bytes': [48], 'logprob': -17.112036}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.466671}, {'token': '10', 'bytes': [49, 48], 'logprob': -17.523176}, {'token': 'It', 'bytes': [73, 116], 'logprob': -17.567091}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -18.159346}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -18.71655}]"
8,21399726,"The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5)",J Support Oncol,"Sleep disorders are a substantial problem for cancer survivors, with prevalence estimates ranging from 23% to 61%. Although numerous prescription hypnotics are available, few are approved for long‐term use or have demonstrated benefit in this circumstance. Hypnotics may have unwanted side effects and are costly, and cancer survivors often wish to avoid prescription drugs. New options with limited side effects are needed. The purpose of this trial was to evaluate the efficacy of a treatment A for sleep in people with cancer who were undergoing cancer treatment. Participants were randomized to receive treatment A or placebo orally 1 hour before bedtime for 8 weeks. The primary end point was area under the curve (AUC) of the overall Pittsburgh Sleep Quality Index (PSQI). Secondary outcomes included the Functional Outcomes of Sleep Questionnaire, the Brief Fatigue Inventory (BFI), and the Profile of Mood States (POMS). Toxicity was evaluated with both self‐reported numeric analogue scale questions and the Common Terminology Criteria for Adverse Events (CTCAE), version 3.0. Questionnaires were completed at baseline and at 4 and 8 weeks. A total of 227 patients were randomized into this study between March 19, 2004, and March 9, 2007. Twenty‐three patients withdrew before starting the study treatment. Primary end‐point data were available on 119 patients (62 receiving treatment A and 57 receiving placebo). Baseline characteristics and baseline patient reported outcomes were well balanced between arms. The AUC over the 8 weeks for treatment A was 51.4 (SD = 16 and for placebo was 49.7 (SD = 15), with a P value of 0.7. The FOSQ was not statistically significantly different between groups. There was no statistically significant difference between groups for the POMS week 8 treatment A 6.9 vs. placebo 6.0; p=0.90. For the BFI at week 8 the treatment A and placebo arm scored respectively for fatigue now 22.1 vs. 10.5; p<0.01; for usual fatigue 19.4 vs. 10.0; p=0.05; for worst fatigue 14.8 vs. 12.4; p=0.65; and for activity inference 12.3 vs. 10.8; p=0.75.There were no significant differences in toxicities as measured by self‐report or the CTCAE. Treatment A was not more effective than placebo on sleep quality in patients who were undergoing cancer treatment.",no_spin,"This passage is about how many cancer survivors have trouble sleeping, and how doctors are trying to find better ways to help them sleep. They did a study where some patients took a new treatment for sleep, while others took a fake pill. They found that the new treatment did not work any better than the fake pill for helping people sleep. They also looked at how tired the patients felt and their mood, but there were no big differences between the two groups. Overall, the new treatment did not seem to be very helpful for cancer patients who were having trouble sleeping.",2,2,"[{'token': '2', 'bytes': [50], 'logprob': -0.618561}, {'token': '3', 'bytes': [51], 'logprob': -0.9848063}, {'token': '4', 'bytes': [52], 'logprob': -2.50235}, {'token': '1', 'bytes': [49], 'logprob': -5.8633385}, {'token': '5', 'bytes': [53], 'logprob': -5.8991547}, {'token': '0', 'bytes': [48], 'logprob': -8.296852}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -10.587795}, {'token': '6', 'bytes': [54], 'logprob': -11.054644}, {'token': '7', 'bytes': [55], 'logprob': -13.029018}, {'token': ' ', 'bytes': [32], 'logprob': -14.364584}, {'token': '\n', 'bytes': [10], 'logprob': -15.783951}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -16.794882}, {'token': '8', 'bytes': [56], 'logprob': -16.90843}, {'token': '-', 'bytes': [45], 'logprob': -17.237587}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.505833}, {'token': 'I', 'bytes': [73], 'logprob': -17.563862}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -17.639969}, {'token': 'score', 'bytes': [115, 99, 111, 114, 101], 'logprob': -17.774431}, {'token': '**', 'bytes': [42, 42], 'logprob': -18.989815}, {'token': 'It', 'bytes': [73, 116], 'logprob': -19.086826}]",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -0.9270098}, {'token': '6', 'bytes': [54], 'logprob': -1.4262011}, {'token': '4', 'bytes': [52], 'logprob': -1.7329867}, {'token': '7', 'bytes': [55], 'logprob': -1.7515719}, {'token': '3', 'bytes': [51], 'logprob': -4.729973}, {'token': '8', 'bytes': [56], 'logprob': -5.3728485}, {'token': '2', 'bytes': [50], 'logprob': -8.210201}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -10.431793}, {'token': '9', 'bytes': [57], 'logprob': -11.158588}, {'token': '1', 'bytes': [49], 'logprob': -13.466892}, {'token': 'I', 'bytes': [73], 'logprob': -13.905146}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -13.9064045}, {'token': '\n', 'bytes': [10], 'logprob': -14.034769}, {'token': ' ', 'bytes': [32], 'logprob': -15.10001}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -15.954357}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -15.976671}, {'token': 'Overall', 'bytes': [79, 118, 101, 114, 97, 108, 108], 'logprob': -16.182285}, {'token': '-', 'bytes': [45], 'logprob': -16.403902}, {'token': '0', 'bytes': [48], 'logprob': -16.694794}, {'token': 'In', 'bytes': [73, 110], 'logprob': -17.156033}]",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -0.7238559}, {'token': '4', 'bytes': [52], 'logprob': -1.5183353}, {'token': '7', 'bytes': [55], 'logprob': -1.9535046}, {'token': '6', 'bytes': [54], 'logprob': -2.108717}, {'token': '3', 'bytes': [51], 'logprob': -3.770506}, {'token': '8', 'bytes': [56], 'logprob': -4.798895}, {'token': '2', 'bytes': [50], 'logprob': -6.4877377}, {'token': '9', 'bytes': [57], 'logprob': -9.74674}, {'token': '1', 'bytes': [49], 'logprob': -12.003054}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -12.183254}, {'token': '\n', 'bytes': [10], 'logprob': -13.358994}, {'token': ' ', 'bytes': [32], 'logprob': -13.684132}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -14.647572}, {'token': 'I', 'bytes': [73], 'logprob': -15.1924305}, {'token': '0', 'bytes': [48], 'logprob': -15.541107}, {'token': '-', 'bytes': [45], 'logprob': -17.085892}, {'token': 'In', 'bytes': [73, 110], 'logprob': -17.213741}, {'token': 'This', 'bytes': [84, 104, 105, 115], 'logprob': -17.352276}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.42392}, {'token': 'Rating', 'bytes': [82, 97, 116, 105, 110, 103], 'logprob': -17.838842}]",5,5,"[{'token': '5', 'bytes': [53], 'logprob': -1.1217788}, {'token': '4', 'bytes': [52], 'logprob': -1.5100883}, {'token': '3', 'bytes': [51], 'logprob': -1.5494865}, {'token': '7', 'bytes': [55], 'logprob': -2.1559548}, {'token': '2', 'bytes': [50], 'logprob': -2.8560014}, {'token': '8', 'bytes': [56], 'logprob': -3.3628793}, {'token': '6', 'bytes': [54], 'logprob': -3.4500985}, {'token': '9', 'bytes': [57], 'logprob': -7.057051}, {'token': '1', 'bytes': [49], 'logprob': -7.7863297}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -9.813261}, {'token': '0', 'bytes': [48], 'logprob': -10.131712}, {'token': 'I', 'bytes': [73], 'logprob': -11.79575}, {'token': ' ', 'bytes': [32], 'logprob': -13.032261}, {'token': '\n', 'bytes': [10], 'logprob': -13.803377}, {'token': '10', 'bytes': [49, 48], 'logprob': -13.858969}, {'token': '-', 'bytes': [45], 'logprob': -14.823708}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -15.633335}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -16.359266}, {'token': 'Based', 'bytes': [66, 97, 115, 101, 100], 'logprob': -16.706503}, {'token': 'It', 'bytes': [73, 116], 'logprob': -16.805634}]",3,3,"[{'token': '3', 'bytes': [51], 'logprob': -0.89600974}, {'token': '4', 'bytes': [52], 'logprob': -1.2891371}, {'token': '2', 'bytes': [50], 'logprob': -1.5774214}, {'token': '5', 'bytes': [53], 'logprob': -2.225199}, {'token': '1', 'bytes': [49], 'logprob': -7.085955}, {'token': '6', 'bytes': [54], 'logprob': -7.7959886}, {'token': '7', 'bytes': [55], 'logprob': -7.8116326}, {'token': '0', 'bytes': [48], 'logprob': -9.717737}, {'token': '8', 'bytes': [56], 'logprob': -10.472101}, {'token': 'Score', 'bytes': [83, 99, 111, 114, 101], 'logprob': -13.831249}, {'token': '\n', 'bytes': [10], 'logprob': -14.710356}, {'token': ' ', 'bytes': [32], 'logprob': -15.037819}, {'token': '9', 'bytes': [57], 'logprob': -15.439911}, {'token': 'The', 'bytes': [84, 104, 101], 'logprob': -17.280643}, {'token': 'I', 'bytes': [73], 'logprob': -17.28426}, {'token': '\n\n', 'bytes': [10, 10], 'logprob': -17.659512}, {'token': '-', 'bytes': [45], 'logprob': -17.938446}, {'token': 'It', 'bytes': [73, 116], 'logprob': -18.308187}, {'token': ' \n', 'bytes': [32, 10], 'logprob': -19.432058}, {'token': '10', 'bytes': [49, 48], 'logprob': -19.733135}]"
